AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glyoka-VM1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Ayati Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glyoka-VM1 Tablet SR

DiabetaComb SR tablets are classified as antidiabetic agents, a combination medication for adult-onset type 2 diabetes. This medication assists in regulating blood glucose. DiabetaComb SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are necessary as advised by your doctor.

Uses of Glyoka-VM1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glyoka-VM1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Glyoka-VM1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

Common Side effects of Glyoka-VM1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glyoka-VM1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyoka-VM1 Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Glyoka-VM1 Tablet SR works:

Glyoka-VM1 sustained-release tablets contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyoka-VM1 SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyoka-VM1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glyoka-VM1 tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Glyoka-VM1 Tablet SR is contraindicated for patients with kidney impairment and should be omitted. Medical advice is essential. Furthermore, its use is discouraged in individuals with advanced kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glyoka-VM1 Tablet SR. Dosage modification may be necessary for these patients. Physician consultation is advised. A low initial dose of Glyoka-VM1 Tablet SR is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glyoka-VM1 Tablet SR :

Should you forget a Glyoka-VM1 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glyoka-VM1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glyoka-VM1 Tablet SR

Glyoka-VM1 SR tablets contain a triple drug formulation: glimepiride, metformin, and voglibose. This medication manages type 2 diabetes mellitus in adults, enhancing blood glucose control when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood glucose. This combination therapy is unsuitable for type 1 diabetes mellitus.
Taking Glyoka-VM1 Tablet SR may result in frequently reported adverse events including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory illness.
Patients with hypersensitivity to any Glyoka-VM1 Tablet SR ingredient or inactive component should not take this medication. Its use is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyoka-VM1 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Glyoka-VM1 Tablet SR can induce hypoglycemia, characterized by low blood sugar. This may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines specified on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glyoka-VM1 Tablet SR
82
MRP 100
18% off